Ocular Therapeutix, Inc. (FRA:0OT)

Ocular Therapeutix Statistics

Total Valuation

FRA:0OT has a market cap or net worth of EUR 2.15 billion. The enterprise value is 1.92 billion.

Market Cap	2.15B
Enterprise Value	1.92B

Important Dates

The next estimated earnings date is Friday, March 6, 2026.

Earnings Date	Mar 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	213.05M
Shares Outstanding	n/a
Shares Change (YoY)	+26.34%
Shares Change (QoQ)	+6.56%
Owned by Insiders (%)	0.94%
Owned by Institutions (%)	76.82%
Float	185.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	45.14
PB Ratio	9.75
P/TBV Ratio	9.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-9.00
EV / Sales	39.92
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.27

Financial Position

The company has a current ratio of 7.85, with a Debt / Equity ratio of 0.30.

Current Ratio	7.85
Quick Ratio	7.62
Debt / Equity	0.30
Debt / EBITDA	n/a
Debt / FCF	-0.39
Interest Coverage	-21.80

Financial Efficiency

Return on equity (ROE) is -81.83% and return on invested capital (ROIC) is -43.27%.

Return on Equity (ROE)	-81.83%
Return on Assets (ROA)	-36.61%
Return on Invested Capital (ROIC)	-43.27%
Return on Capital Employed (ROCE)	-72.99%
Revenue Per Employee	173,518
Profits Per Employee	-776,629
Employee Count	274
Asset Turnover	0.12
Inventory Turnover	65.67

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.52% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+12.52%
50-Day Moving Average	9.98
200-Day Moving Average	8.57
Relative Strength Index (RSI)	52.36
Average Volume (20 Days)	126

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.61

Income Statement

In the last 12 months, FRA:0OT had revenue of EUR 47.54 million and -212.80 million in losses. Loss per share was -1.23.

Revenue	47.54M
Gross Profit	-117.37M
Operating Income	-224.95M
Pretax Income	-212.80M
Net Income	-212.80M
EBITDA	-221.52M
EBIT	-224.95M
Loss Per Share	-1.23

Balance Sheet

The company has 293.85 million in cash and 65.63 million in debt, giving a net cash position of 228.22 million.

Cash & Cash Equivalents	293.85M
Total Debt	65.63M
Net Cash	228.22M
Net Cash Per Share	n/a
Equity (Book Value)	220.09M
Book Value Per Share	1.26
Working Capital	287.81M

Cash Flow

In the last 12 months, operating cash flow was -161.99 million and capital expenditures -7.99 million, giving a free cash flow of -169.98 million.

Operating Cash Flow	-161.99M
Capital Expenditures	-7.99M
Free Cash Flow	-169.98M
FCF Per Share	n/a

Margins

Gross Margin	-246.87%
Operating Margin	-473.14%
Pretax Margin	-447.58%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:0OT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-26.34%
Shareholder Yield	-26.34%
Earnings Yield	-9.92%
FCF Yield	-7.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:0OT has an Altman Z-Score of 1.21 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.21
Piotroski F-Score	1